![]() |
|
|
Vol. 55, Issue 3, 444-452, March 1999
-Aminobutyric AcidA Receptor Pharmacological Properties
Departments of Neurology (J.K., R.L.M.) and Physiology (R.L.M.), University of Michigan Medical Center, Ann Arbor, Michigan
| |
Summary |
|---|
|
|
|---|
Postnatal development of hippocampal dentate granule cell
-aminobutyric acidA (GABAA) receptor
pharmacological properties was studied. Granule cells were acutely
isolated from hippocampi of 7- to 14- and 45- to 52-day-old rats, and
whole cell patch-clamp recordings were obtained. The sensitivity of
GABAA receptors to GABA and modulation of GABAA
receptor currents by benzodiazepines (BZ), zinc, furosemide, and
loreclezole was studied. Multiple changes in the pharmacological
properties of dentate granule-cell GABAA receptors occurred
during the first 52 days of postnatal development: GABA-evoked maximal
current increased with postnatal age; GABAA receptors
changed from BZ type 3 in young rats to BZ type 1 in adult rats;
furosemide and zinc inhibited GABAA receptor currents in
young rats but not in adult rats; the fraction of cells that expressed
loreclezole-sensitive GABAA receptors increased with
postnatal age. These findings suggest that dentate granule cells in
young and adult animals express pharmacologically distinct GABAA receptors and that the postnatal development of these
receptors is prolonged, lasting at least 45 days. Comparison with the
previously reported pharmacological properties of GABAA
receptors on dentate granule cells acutely isolated from hippocampi of
28- to 35-day-old rats suggests that receptors expressed at that age
have properties intermediate between young and adult rats.
| |
Introduction |
|---|
|
|
|---|
-Aminobutyric
acid (GABA) plays several trophic roles during development, including
stimulation of outgrowth of neuronal processes (Behar et al., 1996
),
modulation of DNA synthesis (LoTurco et al., 1995
), and regulation of
neuronal phenotype and depolarization of immature neurons (Ben-Ari et
al., 1994
). The sequence of changes that result in transformation of
GABA from a trophic (Behar et al., 1996
), excitatory neurotransmitter
(Ben-Ari et al., 1994
; Ben-Ari et al., 1997
) in the immature brain to
the major inhibitory neurotransmitter in the forebrain involves changes
in chloride ion reversal potential, changes in expression and
distribution of glutamic acid decarboxylase 67 and 65 (Dupuy and
Houser, 1996
), and late coupling of GABAB
receptors to potassium channels (Ben-Ari et al., 1997
). There is
growing evidence that this transformation also may involve
developmental changes in the subunit subtype composition and properties
of GABAA receptors.
The GABAA receptor is a pentameric subunit
complex that contains specific binding sites for GABA and multiple
allosteric regulators, including picrotoxin, barbiturates,
benzodiazepines (BZs), zinc, and the anesthetic steroids, and
that forms a chloride ion channel (Macdonald and Olsen, 1994
). Based on
sequence similarity, six different GABAA receptor
subunit families have been identified in mammals (
,
,
,
,
, and
) (Macdonald and Olsen, 1994
; Davies et al., 1997
; Whiting
et al., 1997
). Several of the subunit families have multiple subtypes
(
1-
6,
1-
3, and
1-
3). Marked changes occur in the
expression of GABAA receptor subunit subtype mRNAs and receptor polypeptides and functional receptor properties during development (Laurie et al., 1992
; Fritschy et al., 1994
; Mathews
et al., 1994
; Thompson et al., 1996
). Because the subunit composition
of GABAA receptors determines their
pharmacological properties, it is likely that the pharmacological
properties of GABAA receptors change during development.
Granule cells of the hippocampal dentate gyrus provide a useful system
in which to study GABAA receptor development
because many granule cells are born, proliferate, migrate, and mature in the postnatal period (Altman and Das, 1965
; Altman and Das, 1966
;
Gould and Cameron, 1996
). A recent study in dentate granule cells
(Hollrigel and Soltesz, 1997
) demonstrated that until the end of the
second postnatal week, synaptic GABAA
receptor-mediated miniature inhibitory postsynaptic currents (mIPSC)
displayed slower rise and decay kinetics than those of adult granule
cells. It was proposed that these developmental changes in mIPSC
kinetics reflected postnatal development of the properties of the
GABAA receptors.
We report the postnatal development of the properties of
GABAA receptors on dentate granule cells from 7 to 52 days of age. Pharmacological properties of
GABAA receptors on dentate granule cells acutely
isolated from hippocampi of young rats (7-14 days) and adult rats
(45-52 days) were characterized. In the past, we have characterized
the pharmacological properties of GABAA receptors present on dentate granule cells acutely isolated from 28- to 35-day-old rats (Kapur and Macdonald, 1996
); the pharmacological properties of GABAA receptors in these three age
groups were compared.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Isolation.
Dentate granule cells were isolated from
rats aged between 7 and 52 days according to the method described
originally by Kay and Wong (1986)
and later modified (Oh et al., 1995
).
The brain was dissected free, and the region containing the hippocampus was blocked and chilled in an oxygenated
piperazine-N,N'-bis(2-ethanesulfonic acid)
(PIPES) -buffered medium (4°C) for 1 min. The PIPES buffer solution
contained 120 mM NaCl, 2.5 mM KCl, 1.5 mM CaCl2,
1 mM MgCl2, 25 mM
D-glucose, and 20 mM PIPES, pH 7.0. After
blot-drying, the brain was mounted on a vibratome stage, and 500-µm
coronal sections containing the hippocampus were cut. The sections were allowed to recover in oxygenated (95% O2/5%
CO2) PIPES buffer for 30 to 60 min. Hippocampal
sections were then incubated in oxygenated SIGMA type XXIII protease
enzyme (Sigma Chemical Company, St. Louis, MO) in the buffer at 32°C
for 30 to 45 min. The dentate gyrus was dissected out and cut into
0.5-mm cubes that were triturated in a cold (4°C) PIPES-buffered
medium in fire-polished glass pipettes to isolate neurons. The isolated
neurons were plated on poly-L-lysine-coated, 35-mm, polystyrene Petri dishes (Corning Glass Works, Corning, NY), and
the recordings were made within 1 h of isolation.
Whole Cell Recording.
Whole cell GABAA
receptor currents were recorded from hippocampal dentate granule cells
acutely isolated from 7- to 52-day-old rats using the technique
described by Hamill et al., (1981)
. The extracellular recording
solution consisted of 142 mM NaCl, 1.0 mM CaCl2,
8 mM KCl, 6 mM MgCl2, 10 mM glucose, and 10 mM
HEPES, pH adjusted to 7.4 and osmolarity of 310 to 320 mOsM (all
reagents from Sigma). Glass recording patch pipettes were filled with a solution consisting of 115 mM dibasic Trizma phosphate, 30 mM Trizma
base, 11 mM EGTA, 2 mM MgCl2, and 0.5 mM
CaCl2, pH 7.35. Recording pipettes also contained
ATP (2 mM) unless otherwise specified. All recordings were obtained at
room temperature (24°C). With a bathing solution containing a
chloride concentration of 164 mM and whole cell recording pipettes
containing a 5 mM chloride ion solution, the chloride ion concentration
gradient produced a chloride ion equilibrium potential
(ECl
) of
76 mV. Granule cells were
voltage-clamped to 0 mV; thus, application of GABA produced outward
currents. Patch pipettes (resistance of 6-10 M
) were pulled on P-87
Flaming Brown puller by a four-stage pull. Currents were recorded with
an Axopatch 200 A amplifier (Axon Instruments, Foster City, CA) and
low-pass filtered at 2 kHz with an eight-pole Bessel filter
(Frequency Devices, Haverhill, MA) before digitization, storage, and
display. Currents were displayed on a Gould 2400S chart
recorder, and peak whole cell currents were measured manually
from the chart paper. Currents were also recorded on a hard disk using
the Axotape or Axoscope program (digitized at 208 Hz) and on a video
cassette tape recorder (Sony SL-HF360) via a digital audio processor
(Sony PCM-501 ES, 14-bit, 44 kHz).
Drug Application.
GABA, zolpidem, and
ZnCl2 dissolved in extracellular solution were
applied to neurons using a modified U-tube "multipuffer" rapid
application system (Greenfield and Macdonald, 1996
), with the tip of
application pipette placed 100 to 200 µm from the cell. Diazepam and
furosemide were dissolved first in dimethyl sulfoxide and then diluted
in extracellular buffer; the final dimethyl sulfoxide dilution was at
least 1:50,000. GABA, diazepam, and ZnCl2 were obtained from Sigma. Zolpidem was obtained from Research Biochemicals, Inc. (Natick, MA).
Data Analysis.
The magnitude of the enhancement or
inhibition of GABAA receptor current by a drug
was determined by dividing the peak amplitude of
GABAA receptor current elicited in the presence
of a given concentration of the drug and GABA by the peak amplitude of
control current elicited by GABA alone and multiplying the fraction by 100 to express it as percentage control. The control response was
100%. Peak GABAA receptor currents at various
drug concentrations were fitted to a sigmoidal function using a
four-parameter logistic equation (sigmoidal concentration-response)
with a variable slope. The equation used to fit the
concentration-response relationship was
|
| |
Results |
|---|
|
|
|---|
Maximal GABAA Receptor Current Amplitude Increased During Development. GABA at concentrations ranging from 0.3 to 1000 µM was applied to granule cells isolated from 7- to 14-day-old rats with recovery intervals of at least 1 min (Fig. 1A). In these cells, the minimum concentration of GABA required for evoking currents was 1 µM, and the peak current elicited by 10 µM GABA was 40 ± 10 pA (n = 7). In contrast, GABA evoked larger currents from granule cells isolated from 45- to 52-day-old rats (Fig. 1B). In these cells, the minimum concentration of GABA required for evoking currents was 0.3 µM, and the peak current elicited by 10 µM GABA was 252 ± 64 pA (n = 8, p < .01, unpaired t test) (Fig. 1B). GABA concentration-response curves were obtained from individual granule cells isolated from 7- to 14- (n = 7) and 45- to 52-day-old rats (n = 8) (Fig. 2) for GABA concentrations ranging from 1 to 1000 µM. The maximal GABAA receptor current increased with age. Maximal GABAA receptor current elicited from granule cells isolated from younger rats was 476 ± 65 pA (n = 8), whereas maximal current elicited from granule cells isolated from older rats was 893 ± 160 pA (n = 7, p < .01, unpaired t test) (Figs. 1 and 2). GABA potency did not change significantly during this developmental period; the GABA EC50 value for granule cells from younger rats was 40 ± 8 µM, whereas the GABA EC50 value for granule cells from older rats was 31 ± 10 µM (p > .05) (Fig. 2).
|
|
BZ Sensitivity of Granule Cell GABAA Receptors Increased During Development. Diazepam (100 nM) was coapplied with 10 µM GABA to granule cells isolated from 7- to 14-day-old rats and compared with peak currents elicited by GABA alone. There was minimal enhancement of peak currents by 100 nM diazepam [12 ± 8% larger than control currents (n = 3)] (Fig. 3A). In contrast, in granule cells isolated from 45- to 52-day-old rats, 100 nM diazepam enhanced GABAA receptor currents elicited by 10 µM GABA by 53 ± 13%, (p < .01, n = 4, ANOVA with post-test Newman-Keuls multiple comparison test, compared with enhancement by 100 or 1000 nM diazepam in cells from 7- to 14-day-old rats) (Fig. 3B).
|
|
Zinc Sensitivity of Granule Cell GABAA Receptors
Declined during Development.
The BZ modulation of
GABAA receptor currents in dentate granule cells
isolated from 7- to 14-day-old rats suggested the presence of BZ 3 receptors on these cells. Recombinant receptors containing an
4 or
6 subtype, with
and
2 subtypes, have BZ 3 pharmacology (Wieland et al., 1992
) with moderate zinc sensitivity [zinc 50% inhibitory concentration (IC50) value of 30-70
µM for inhibition of GABAA receptor currents]
(Knoflach et al., 1996
; Saxena and Macdonald, 1996
). In contrast, BZ
modulation of GABAA receptor currents in dentate
granule cells isolated from 45- to 52-day-old rats suggested the
presence of BZ 1 receptors. Recombinant
1
x
2 receptors were
minimally zinc sensitive (zinc IC50 value of > 100 µM for inhibition of GABAA receptor
currents) (Saxena and Macdonald, 1996
).
|
Furosemide Sensitivity of Granule Cell GABAA Receptor
Currents Declined during Development.
Dentate granule cells from
7- to 14-day-old rats expressed GABAA receptors
that were relatively insensitive to diazepam and zolpidem but were
sensitive to Ro-15-4513 (data not shown), which suggests BZ 3 pharmacology. In contrast, GABA receptors from 45- to 52-day-old rats
expressed GABAA receptors with high diazepam and
zolpidem sensitivity, consistent with BZ 1 pharmacology. Recombinant GABAA receptors that contained the
1 subtype
and had BZ 1 pharmacology also had low sensitivity to furosemide
inhibition of GABAA receptor currents, whereas
4 or
6 subtype-containing diazepam-insensitive receptors with BZ
3 pharmacology had high sensitivity to furosemide (Wafford et al.,
1996
).
300 µM (Fig.
6A), but in cells from 45- to 52-day-old
rats, 300 µM furosemide did not inhibit the
GABAA receptor currents (Fig. 6B). When fitted to
the equation for a sigmoidal function, the IC50
value for inhibition of GABAA receptor currents
in granule cells isolated from 7- to 14-day-old rats was 492 ± 79 µM, whereas that for cells isolated from 45- to 52-day-old rats was
1605 ± 199 µM (p < .05, unpaired t
test, Fig. 6C). The maximal inhibition by furosemide could not be
compared because the inhibition curves did not plateau at high
furosemide concentrations (Fig. 6C). Higher concentrations of
furosemide could not be applied because of its poor solubility.
|
300 µM (Fig. 6C). The data could
not be fit by a single sigmoidal function. Visual analysis of the data
suggested a two-site fit; however, the EC50 value
for the lower affinity site could not be confidently determined. Visual
analysis of the data suggested that furosemide inhibited
GABAA receptor currents at concentrations that
were intermediate to those aged 7 to 14 days and 45 to 52 days.
Fraction of Granule Cells Sensitive to Loreclezole Increased during
Development.
The antiepileptic drug loreclezole has been shown to
enhance recombinant GABAA receptor currents via a
specific modulatory site on GABAA receptor
subunits. The action of loreclezole depended on the
subtype
expressed. Isoforms containing
2 or
3 subtypes had a 300-fold
lower EC50 value for loreclezole enhancement of GABAA receptor current than isoforms containing
the
1 subtype (Wafford et al., 1994
). Additionally, at
concentrations above 6 µM, loreclezole enhanced the degree and rate
of apparent desensitization in a concentration-dependent manner
(Donnelly and Macdonald, 1996
). This inhibitory effect of loreclezole
occurred regardless of subunit composition of the receptor.
|
| |
Discussion |
|---|
|
|
|---|
Multiple changes in the pharmacological properties of dentate granule-cell GABAA receptors occurred during the first 52 days of postnatal development: maximal GABA-evoked current increased with postnatal age; GABAA receptors changed from type BZ 3 in young rats to type BZ 1 in adult rats; furosemide and zinc inhibited GABAA receptor currents in young rats but not in adult rats; and the fraction of cells expressing loreclezole sensitive GABAA receptors increased with postnatal age. This transformation was gradual, and granule cells isolated from 28- to 35-day-old rats expressed receptors with pharmacological properties that were intermediate between younger and older rats.
Prolonged Postnatal Development of Dentate Granule Cell
GABAA Receptors.
The findings of this study and our
previously published study (Kapur and Macdonald, 1996
) suggest that the
pharmacological properties of dentate granule-cell
GABAA receptors undergo prolonged development
lasting up to at least postnatal day 52. There was prolonged postnatal
development of GABAA receptor-mediated,
paired-pulse inhibition in the dentate gyrus (Bronzino et al., 1996
).
The prolonged postnatal maturation of GABAA
receptors was quite similar to the morphological maturation of dentate
granule cells (Bayer and Altman, 1974
). The granule cell population of
the dentate gyrus has the distinctive characteristic of neuronal birth,
migration, and death occurring over an extended period of time
beginning in gestation and extending to adulthood (Altman and Das,
1965
; Gould and Cameron, 1996
). The proliferation and migration of
granule cells reached its peak in rats in first 2 postnatal weeks and
then began to decline (Bayer and Altman, 1974
; Schlessinger et al.,
1975
). The maximum number of immature postnatal granule cells was
present at 2 weeks of age and declined to a low level at 2 months of
age. Mature granule cells accumulated from the first week; their number reached an asymptotic level at 30 to 70 days.
Postnatal Development of GABAA Receptor Currents.
The maximal current elicited by GABA increased significantly from day
14 to day 28 and then remained stable at age 52 days (Table
1). The increase in the magnitude of
whole cell GABAA receptor currents observed
during postnatal development could have been caused by an increased
receptor density present at each synapse, an increase in the density of
extrasynaptic receptors, an increase in the number of GABAergic
synapses on each dentate granule cell, or a combination of these
factors. An increase in the density of synaptic
GABAA receptors seemed unlikely, because the peak
amplitude of miniature IPSCs did not change during development (Hollrigel and Soltesz, 1997
) and the miniature IPSC peak current was
determined by the number of postsynaptic GABAA
receptors (Edwards et al., 1989
; Mody et al., 1994
). An increase in the
size of granule cells with an associated proportional increase in
synaptic and extrasynaptic GABAA receptors could
explain the larger whole cell GABAA receptor
currents in cells from older rats. Histological studies demonstrated
that immature granule cells were small, whereas mature cells could be
small or large, and the number of mature granule cells continued to
increase up to postnatal day 70 (Bayer and Altman, 1974
). This could
result in increased GABAergic synapses on mature granule cells and
increased extrasynaptic GABAA receptors. However,
the current study did not systematically evaluate cell dentate granule
cell volume at various ages by capacitance measurement. Thus the
increase in GABAA receptor currents could have
resulted from a combination of these factors.
|
Postnatal Development of BZ, Zinc, and Furosemide Modulation of
Dentate Granule Cell GABAA Receptor Currents.
Dentate
granule cells from 7- to 14-day-old rats expressed
GABAA receptor currents that were poorly enhanced
by diazepam and zolpidem, whereas GABAA receptor
currents from 45- to 52-day-old rats were enhanced with high affinity
by diazepam and zolpidem (Table 1). These data suggested that BZ 3 receptors were expressed early in postnatal development and were
transformed to BZ 1 receptors by 45 to 52 days of age.
GABAA receptors present on cells from 28- to
35-day-old rats (Table 1) had intermediate BZ sensitivity and could not
be classified as BZ 1, BZ 2, or BZ 3 receptors (for details, see Kapur
and Macdonald, 1996
). Data from the previous study combined with those
reported here suggest that transformation of granule-cell
GABAA receptors from BZ 3 to BZ 1 receptors is a
gradual process with a clear intermediate state.
Possible Molecular Bases for Developmental Changes in BZ, Zinc, and
Furosemide Modulation of Dentate Granule Cell GABAA
Receptor Currents.
The most likely explanation for changes in the
pharmacological properties of dentate granule-cell
GABAA receptors during development was that
different receptor isoforms were expressed at 7 to 14, 28 to 35, and 45 to 52 days of age. The pharmacological properties of
GABAA receptors in granule cells from 7- to
14-day-old rats were similar to those of recombinant receptors
containing
4,
2, and
1 or
3 subtypes. The presence of an
4 or
6 subtype along with a
2 subtype would explain the low
affinity for diazepam, moderate affinity for zinc, and relatively high
sensitivity to furosemide. GABAA receptors in 45- to 52-day-old rats had high diazepam and zolpidem sensitivities but
were relatively insensitive to zinc and furosemide. Recombinant
receptors containing
1,
2, and
x subtypes also have these properties.
1 and
2
subtype immunoreactivity on dentate granule cells (Fritschy et al.,
1994
1 Subtype immunoreactivity was low in dentate granule cells
at birth and increased by 20 days of age.
2 Subtype immunoreactivity
was present at birth and continued unchanged to 20 days of age.
Coexpression of
1 and
2 subtype immunoreactivity on same neurons
was directly demonstrated by confocal laser microscopy in several
regions. Coexpression of two
subtypes on dentate granule cells at
28 to 35 days of age could explain their intermediate BZ and furosemide
sensitivity. The developmental changes in
subtype mRNA also
followed the pattern of low
1 mRNA at birth and high
2 mRNA
expression from birth to adulthood (Laurie et al., 1992
1,
2,
4,
3,
2, and
but no
6
immunoreactivities were observed within the molecular layer of the
dentate gyrus. The pharmacological properties of
GABAA receptors on 45- to 52-day-old rats were
consistent with the expression of at least three of these subunits,
1,
3,
2, and
.
Other possible explanations for the developmental changes in the
pharmacological properties of granule-cell GABAA
receptors included the absence of a
2 subtype in receptors on
granule cells from young rats or post-translational modification of
receptors. However, absence of the
2 subtype would be inconsistent
with the presence of moderate zinc sensitivity and enhancement by high concentrations of diazepam. Also, modification of
GABAA receptor pharmacological properties by
post-translational modification has not been demonstrated.
Development of Loreclezole Sensitivity.
The action of
loreclezole on recombinant GABAA receptors
depends on the
subtype expressed. Isoforms containing
2 or
3 subtypes had a 300-fold lower EC50 value for
loreclezole enhancement of GABAA receptor current
than isoforms containing the
1 subtype (Wafford et al., 1994
). High
loreclezole sensitivity depends on the presence of a
2 or
3
subtype without a
1 subtype (Fisher and Macdonald, 1997
). This
suggests that 30% of granule cells in 7- to 14-day-old rats, 50% of
granule cells in 28- to 35-day-old rats, and 70% of granule cells in
45- to 52-day-old rats expressed GABAA receptor
with only
2 and/or
3 subtypes. The continued presence of granule
cells expressing GABAA receptors not enhanced by
loreclezole at 45 to 52 days of age may reflect continued presence of
immature granule cells to this age (Bayer and Altman, 1974
). In
addition to enhancement of peak GABAA receptor
currents, loreclezole was demonstrated to enhance the degree and rate
of apparent desensitization in a concentration-dependent manner
(Donnelly and Macdonald, 1996
). This inhibitory effect of loreclezole
occurred regardless of subunit composition of the receptor and was
apparent in cells isolated from all three age groups.
GABAA Receptor Development in Other Regions of the
Brain.
During development, changes in the properties of
GABAA receptors present in many different regions
of the brain have been described. The properties and subunit
composition of GABAA receptors on cultured
cerebellar granule cells changed during development (Mathews et al.,
1994
). Cerebellar granule cells expressed BZ-sensitive
1-subtype-containing GABAA receptors after 5 to 7 days in culture, but mature granule cells, 21 to 25 days in
culture, expressed
6-containing BZ-insensitive
GABAA receptors. In hippocampal CA3 neurons in
slices from young animals before 15 days of age, zolpidem enhanced
IPSPs poorly and BZ action was mediated through BZ 2 receptors, whereas
in slices from adult animals, BZ 1 receptors were present (Rovira and
Ben-Ari, 1993
). GABAA receptors present on rat
thalamic reticular neurons (Gibbs, III et al., 1996
) and principal
neurons (Oh et al., 1995
) also undergo developmental regulation with
changes in maximal current and BZ regulation.
| |
Footnotes |
|---|
Received October 13, 1998; Accepted November 24, 1998
1 Current address: Department of Neurology, University of Virginia, Health Sciences Center, Charlottesville, Virginia.
This work was supported by grants from the US Public Health Service (RO1-33300, R.L.M.; KO8-NS01748, J.K.) and Epilepsy Foundation of America (J.K.).
Send reprint requests to: Robert L. Macdonald, M.D., Ph.D., Neuroscience Laboratory Building, 1103 East Huron, Ann Arbor, MI 48104-1687. E-mail: rlmacd{at}umich.edu
| |
Abbreviations |
|---|
GABA,
-aminobutyric acid;
IPSC, inhibitory
postsynaptic current;
PIPES, piperazine-N,N'-bis(2-ethanesulfonic acid);
IC50, 50% inhibitory concentration;
BZ, benzodiazepine.
| |
References |
|---|
|
|
|---|
subunit subtypes.
Neuropharmacology
36:
1601-1610[Medline].
1
1
2S GABAA receptor currents elicited by a "multipuffer" drug application device.
Pflugers Arch
432:
1080-1090[Medline].
-aminobutyric acidA receptors from acutely dissociated rat dentate granule cells.
Mol Pharmacol
50:
458-466[Abstract].
-aminobutyric acidA receptors
4
2
2 and
6
2
2.
Mol Pharmacol
50:
1253-1261[Abstract].
1 and
6 subunits in cultured rat cerebellar granule cells.
Neuropharmacology
35:
1337-1346[Medline].
-aminobutyric acidA receptors containing the
4 subunit.
Mol Pharmacol
50:
670-678[Abstract].This article has been cited by other articles:
![]() |
V. C. Kotak, A. E. Takesian, and D. H. Sanes Hearing Loss Prevents the Maturation of GABAergic Transmission in the Auditory Cortex Cereb Cortex, September 1, 2008; 18(9): 2098 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mtchedlishvili and J. Kapur High-Affinity, Slowly Desensitizing GABAA Receptors Mediate Tonic Inhibition in Hippocampal Dentate Granule Cells Mol. Pharmacol., February 1, 2006; 69(2): 564 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Mangan, C. Sun, M. Carpenter, H. P. Goodkin, W. Sieghart, and J. Kapur Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors Mol. Pharmacol., March 1, 2005; 67(3): 775 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Simeone, S. D. Donevan, and J. M. Rho Molecular Biology and Ontogeny of {gamma}-Aminobutyric Acid (GABA) Receptors in the Mammalian Central Nervous System J Child Neurol, January 1, 2003; 18(1): 39 - 48. [Abstract] [PDF] |
||||
![]() |
M. I. Banks, J. B. Hardie, and R. A. Pearce Development of GABAA Receptor-Mediated Inhibitory Postsynaptic Currents in Hippocampus J Neurophysiol, December 1, 2002; 88(6): 3097 - 3107. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Dunning, C. L. Hoover, I. Soltesz, M. A. Smith, and D. K. O'Dowd GABAA Receptor-Mediated Miniature Postsynaptic Currents and alpha -Subunit Expression in Developing Cortical Neurons J Neurophysiol, December 1, 1999; 82(6): 3286 - 3297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saito, R. Matoba, N. Ueno, K. Matsubara, and K. Kato Comparison of gene expression profiling during postnatal development of mouse dentate gyrus and cerebellum Physiol Genomics, February 28, 2002; 8(2): 131 - 137. [Abstract] [Full Text] [PDF] |
||||
| ||||||||